Author: Dr. David Lowemann

Novo Nordisk Expands Wegovy Access Via 3 Telehealth Firms

Novo Nordisk said Tuesday it was partnering with telehealth firms Hims & Hers , Ro and LifeMD to sell branded versions of Wegovy, ahead of potential restrictions on selling compounded versions of the obesity drug. Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a co-founder of the Institute for the […]

Published on April 29, 2025

Better Lifestyle Could Prevent Most Cardiac Arrests

Nearly two-thirds of cardiac arrest cases could be prevented by managing lifestyle, environmental and personal health risks, a new study says. Researchers found that addressing 56 everyday risk factors for sudden cardiac arrest (SCA) could prevent up to 63% of cases,… Read Full Article (External Site) Dr. David LowemannDr. David Lowemann, M.Sc, Ph.D., is a […]

Published on April 29, 2025

Study: Autism Does Not Accelerate Brain Aging

People with autism do not appear to be at greater risk of age-related brain decline, a new study says. Older people with autistic traits have no differences when it comes to spatial working memory, which helps folks remember and use information about where things are and how… Read Full Article (External Site) Dr. David LowemannDr. […]

Published on April 29, 2025